Clinical Trial: Anti-VEGF Versus Prompt Laser or Observation for Proliferative Sickle Cell Retinopathy (ALPS)

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07922460) titled 'Anti-VEGF Versus Prompt Laser or Observation for Proliferative Sickle Cell Retinopathy (ALPS)' on Nov. 02.

Brief Summary: The purpose of the study is to determine if anti-VEGF/anti-Ang2 therapy results in prevention of vitreous hemorrhage or retinal detachment as compared to localized scatter laser photocoagulation in patients with stage 3 Proliferative sickle retinopathy (PSR) and to determine if anti-VEGF therapy results in significant clearing of vitreous hemorrhage and faster improvement of visual acuity as compared to observation

Study Start Date: Dec. 01

Study Type: INTERVENTIONAL

Condition: Proliferative Sickle Cell Retino...